Merit Medical Systems, Inc. (NASDAQ:MMSI) Stock Has Average Target Price of $100.00

Key Points

• Analysts maintain a “Moderate Buy” consensus on Merit Medical Systems, with eight buy ratings, three holds, and one strong-buy rating. The average 12-month price target is $100, above the reported opening price of $87.50.
• Merit Medical exceeded quarterly expectations, reporting $1.19 EPS versus the $0.96 consensus and revenue of $418.84 million, up 9.5% year over year.
• Institutional investors own 99.66% of the company, while the stock trades near its 52-week high with a market capitalization of approximately $5.22 billion.

Merit Medical Systems, Inc. (NASDAQ:MMSI - Get Free Report) has been given an average recommendation of "Moderate Buy" by the twelve brokerages that are presently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation, eight have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $100.00.

A number of research firms have recently weighed in on MMSI. Barrington Research set a $114.00 price objective on Merit Medical Systems in a research report on Friday, July 31st. Piper Sandler increased their price target on Merit Medical Systems from $96.00 to $106.00 and gave the company an "overweight" rating in a research report on Friday, July 31st. Bank of America lifted their price objective on Merit Medical Systems from $92.00 to $97.00 and gave the company a "neutral" rating in a research note on Thursday, August 13th. Needham & Company LLC boosted their price objective on Merit Medical Systems from $90.00 to $101.00 and gave the stock a "buy" rating in a research report on Friday, July 31st. Finally, Zacks Research upgraded shares of Merit Medical Systems from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, August 25th.

Merit Medical Systems Price Performance

MMSI stock opened at $87.50 on Friday. Merit Medical Systems has a 1 year low of $59.74 and a 1 year high of $94.75. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.20 and a quick ratio of 2.79. The firm has a market capitalization of $5.22 billion, a PE ratio of 36.16, a price-to-earnings-growth ratio of 2.18 and a beta of 0.49. The business has a 50 day simple moving average of $86.34 and a 200-day simple moving average of $74.07.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.23. Merit Medical Systems had a net margin of 9.22% and a return on equity of 13.75%. The business had revenue of $418.84 million during the quarter, compared to analysts' expectations of $405.25 million. During the same quarter in the prior year, the company posted $1.01 EPS. The business's revenue for the quarter was up 9.5% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. Equities research analysts anticipate that Merit Medical Systems will post 3.84 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Merit Medical Systems

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Conestoga Capital Advisors LLC lifted its position in shares of Merit Medical Systems by 3.9% during the 1st quarter. Conestoga Capital Advisors LLC now owns 2,167,513 shares of the medical instruments supplier's stock worth $149,407,000 after purchasing an additional 81,030 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in Merit Medical Systems by 1.0% in the first quarter. Dimensional Fund Advisors LP now owns 1,237,298 shares of the medical instruments supplier's stock valued at $85,287,000 after buying an additional 12,285 shares during the last quarter. William Blair Investment Management LLC acquired a new stake in Merit Medical Systems in the second quarter valued at $78,894,000. Norges Bank acquired a new stake in Merit Medical Systems in the fourth quarter valued at $75,957,000. Finally, Maverick Capital Ltd. lifted its holdings in Merit Medical Systems by 46.9% during the 1st quarter. Maverick Capital Ltd. now owns 714,081 shares of the medical instruments supplier's stock worth $49,222,000 after buying an additional 227,915 shares during the last quarter. 99.66% of the stock is currently owned by institutional investors and hedge funds.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a medical device company that develops, manufactures and markets disposable products used in interventional, diagnostic and therapeutic procedures. Its portfolio is designed primarily for use by physicians in hospitals, outpatient facilities and other healthcare settings.

The company's products support a range of specialties, including cardiovascular intervention, peripheral intervention, oncology, spine and pain management, general surgery, and critical care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.